Back to top

LACOG 0119

  /    /  LACOG 0119

Multicenter retrospective database on prognostic and predictive factors in patients with neuroendocrine tumors

Type of Study: Epidemiological

Sponsor / Support: LACOG

Primary Objectives: Compare overall survival between TNE-BD vs CNE-PD and between functioning vs non-functioning tumors; and to evaluate the response rate, progression-free survival, clinical benefit, time until symptom control and the incidence of disease complications and / or treatment in each analyzed group.

Design: Retrospective, multicenter study that will evaluate patients with neuroendocrine tumor 

Sample Size: 300 patients

Principal Investigator: Rachel Riechelmann

Countries LATAM: Brazil